Visualization of bile homeostasis using 1H-NMR spectroscopy as a route for assessing liver cancer

G. A. Nagana Gowda, Narasimhamurthy Shanaiah, Amanda Cooper, Mary Maluccio, Daniel Raftery

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Changes in bile synthesis by the liver or alterations in the enterohepatic circulation due to a variety of etiological conditions may represent a novel source of liver disease-specific biomarkers. Bile from patients with liver diseases exhibited significant changes in the levels of glycine- and taurine-conjugated bile acids, phospholipids, cholesterol and urea relative to non-liver disease controls. Cholangiocarcinoma and non-malignant liver diseases (NMLD) showed the most significant alterations. Further, hepatocellular carcinoma (HCC) could be differentiated from NMLD (p = 0.02), as well as non-liver disease controls (p = 0.02) based on the amounts of bile acids, phospholipids and/or cholesterol. HCC also differed with cholangiocarcinoma although not significantly. Urea increases somewhat in non-malignant liver disease relative to non-liver disease controls, while the bile acids, phospholipids and cholesterol all decrease significantly. The ratio between some major bile metabolites also distinguished NMLD (p = 0.004-0.01) from non-liver disease controls. This snapshot view of bile homeostasis, is obtainable from a simple nuclear magnetic resonance (NMR) approach and demonstrates the enormous opportunity to assess liver status, explore biomarkers for high risk diseases such as cancers and improve the understanding of normal and abnormal cellular functions.

Original languageEnglish (US)
Pages (from-to)27-35
Number of pages9
JournalLipids
Volume44
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Liver Neoplasms
Bile
Liver
Nuclear magnetic resonance spectroscopy
Liver Diseases
Homeostasis
Magnetic Resonance Spectroscopy
Visualization
Disease control
Bile Acids and Salts
Phospholipids
Cholangiocarcinoma
Cholesterol
Urea
Hepatocellular Carcinoma
Biomarkers
Enterohepatic Circulation
Taurine
Glycine
Metabolites

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Organic Chemistry
  • Cell Biology

Cite this

Nagana Gowda, G. A. ; Shanaiah, Narasimhamurthy ; Cooper, Amanda ; Maluccio, Mary ; Raftery, Daniel. / Visualization of bile homeostasis using 1H-NMR spectroscopy as a route for assessing liver cancer. In: Lipids. 2009 ; Vol. 44, No. 1. pp. 27-35.
@article{60014d7227384ab2a1f42893f1d76f8c,
title = "Visualization of bile homeostasis using 1H-NMR spectroscopy as a route for assessing liver cancer",
abstract = "Changes in bile synthesis by the liver or alterations in the enterohepatic circulation due to a variety of etiological conditions may represent a novel source of liver disease-specific biomarkers. Bile from patients with liver diseases exhibited significant changes in the levels of glycine- and taurine-conjugated bile acids, phospholipids, cholesterol and urea relative to non-liver disease controls. Cholangiocarcinoma and non-malignant liver diseases (NMLD) showed the most significant alterations. Further, hepatocellular carcinoma (HCC) could be differentiated from NMLD (p = 0.02), as well as non-liver disease controls (p = 0.02) based on the amounts of bile acids, phospholipids and/or cholesterol. HCC also differed with cholangiocarcinoma although not significantly. Urea increases somewhat in non-malignant liver disease relative to non-liver disease controls, while the bile acids, phospholipids and cholesterol all decrease significantly. The ratio between some major bile metabolites also distinguished NMLD (p = 0.004-0.01) from non-liver disease controls. This snapshot view of bile homeostasis, is obtainable from a simple nuclear magnetic resonance (NMR) approach and demonstrates the enormous opportunity to assess liver status, explore biomarkers for high risk diseases such as cancers and improve the understanding of normal and abnormal cellular functions.",
author = "{Nagana Gowda}, {G. A.} and Narasimhamurthy Shanaiah and Amanda Cooper and Mary Maluccio and Daniel Raftery",
year = "2009",
month = "1",
day = "1",
doi = "10.1007/s11745-008-3254-6",
language = "English (US)",
volume = "44",
pages = "27--35",
journal = "Lipids",
issn = "0024-4201",
publisher = "Springer Verlag",
number = "1",

}

Visualization of bile homeostasis using 1H-NMR spectroscopy as a route for assessing liver cancer. / Nagana Gowda, G. A.; Shanaiah, Narasimhamurthy; Cooper, Amanda; Maluccio, Mary; Raftery, Daniel.

In: Lipids, Vol. 44, No. 1, 01.01.2009, p. 27-35.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Visualization of bile homeostasis using 1H-NMR spectroscopy as a route for assessing liver cancer

AU - Nagana Gowda, G. A.

AU - Shanaiah, Narasimhamurthy

AU - Cooper, Amanda

AU - Maluccio, Mary

AU - Raftery, Daniel

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Changes in bile synthesis by the liver or alterations in the enterohepatic circulation due to a variety of etiological conditions may represent a novel source of liver disease-specific biomarkers. Bile from patients with liver diseases exhibited significant changes in the levels of glycine- and taurine-conjugated bile acids, phospholipids, cholesterol and urea relative to non-liver disease controls. Cholangiocarcinoma and non-malignant liver diseases (NMLD) showed the most significant alterations. Further, hepatocellular carcinoma (HCC) could be differentiated from NMLD (p = 0.02), as well as non-liver disease controls (p = 0.02) based on the amounts of bile acids, phospholipids and/or cholesterol. HCC also differed with cholangiocarcinoma although not significantly. Urea increases somewhat in non-malignant liver disease relative to non-liver disease controls, while the bile acids, phospholipids and cholesterol all decrease significantly. The ratio between some major bile metabolites also distinguished NMLD (p = 0.004-0.01) from non-liver disease controls. This snapshot view of bile homeostasis, is obtainable from a simple nuclear magnetic resonance (NMR) approach and demonstrates the enormous opportunity to assess liver status, explore biomarkers for high risk diseases such as cancers and improve the understanding of normal and abnormal cellular functions.

AB - Changes in bile synthesis by the liver or alterations in the enterohepatic circulation due to a variety of etiological conditions may represent a novel source of liver disease-specific biomarkers. Bile from patients with liver diseases exhibited significant changes in the levels of glycine- and taurine-conjugated bile acids, phospholipids, cholesterol and urea relative to non-liver disease controls. Cholangiocarcinoma and non-malignant liver diseases (NMLD) showed the most significant alterations. Further, hepatocellular carcinoma (HCC) could be differentiated from NMLD (p = 0.02), as well as non-liver disease controls (p = 0.02) based on the amounts of bile acids, phospholipids and/or cholesterol. HCC also differed with cholangiocarcinoma although not significantly. Urea increases somewhat in non-malignant liver disease relative to non-liver disease controls, while the bile acids, phospholipids and cholesterol all decrease significantly. The ratio between some major bile metabolites also distinguished NMLD (p = 0.004-0.01) from non-liver disease controls. This snapshot view of bile homeostasis, is obtainable from a simple nuclear magnetic resonance (NMR) approach and demonstrates the enormous opportunity to assess liver status, explore biomarkers for high risk diseases such as cancers and improve the understanding of normal and abnormal cellular functions.

UR - http://www.scopus.com/inward/record.url?scp=57849135426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57849135426&partnerID=8YFLogxK

U2 - 10.1007/s11745-008-3254-6

DO - 10.1007/s11745-008-3254-6

M3 - Article

C2 - 18982376

AN - SCOPUS:57849135426

VL - 44

SP - 27

EP - 35

JO - Lipids

JF - Lipids

SN - 0024-4201

IS - 1

ER -